Document is current
Any future updates will be listed below
-
Authors
Pasricha, Sachin V.
Cohen, Debbie L.
Shulman, Rachel
Byfield, Rushelle https://orcid.org/0000-0002-4673-7118
Cohen, Jordana B. https://orcid.org/0000-0003-4649-079X
,
Anderson, Amanda H.
Appel, Lawrence J.
Chen, Jing
Cohen, Debbie L.
Dember, Laura M.
Go, Alan S.
Hamm, L. Lee
Lash, James P.
Rahman, Mahboob
Rao, Panduranga S.
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (U24DK060990)
- License Information
-
More Information
Article History
Received: 21 January 2026
Revised: 23 April 2026
Accepted: 27 May 2026
First Online: 6 June 2026
Competing interests
: SVP reports receiving consulting fees from AstraZeneca, travel support from Boehringer Ingelheim, and educational funding from Medtronic. DLC, RB, RS, and JBC have no relevant financial conflicts of interest to declare.
: This study was approved by the University of Pennsylvania Institutional Review Board No. 853884. The study was conducted with full adherence to the principles outlined in the Declaration of Helsinki.
